American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MarketAxess Holdings
MKTX
|
+$239M |
| 2 |
Eli Lilly
LLY
|
+$204M |
| 3 |
Duke Energy
DUK
|
+$179M |
| 4 |
Colgate-Palmolive
CL
|
+$178M |
| 5 |
Labcorp
LH
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$265M |
| 2 |
Emerson Electric
EMR
|
+$236M |
| 3 |
Quest Diagnostics
DGX
|
+$200M |
| 4 |
Aflac
AFL
|
+$139M |
| 5 |
ServiceNow
NOW
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 15.07% |
| 4 | Consumer Discretionary | 10.54% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Riot Platforms
RIOT
$7.63B
| $127K | ﹤0.01% |
37,479
+26,299
| +235% | +$136K |
|
|
SGMO
2377
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $126K | ﹤0.01% |
40,239
+4,333
| +12% | +$16.8K |
|
2378
Editas Medicine
EDIT
$436M
| $124K | ﹤0.01% |
+14,023
| New | +$154K |
|
|
LICY
2379
DELISTED
Li-Cycle Holdings Corp.
LICY
| $123K | ﹤0.01% |
3,240
+1,573
| +94% | +$70.6K |
|
|
TIGR
2380
UP Fintech Holding
TIGR
$818M
| $123K | ﹤0.01% |
+36,001
| New | +$156K |
|
|
AZUL
2381
DELISTED
Azul
AZUL
| $121K | ﹤0.01% |
19,869
+6,437
| +48% | +$50.2K |
|
2382
Protagonist Therapeutics
PTGX
$9.84B
| $121K | ﹤0.01% |
+11,056
| New | +$93.3K |
|
2383
Equinox Gold
EQX
$13.5B
| $118K | ﹤0.01% |
35,980
-221,000
| -86% | -$762K |
|
|
BBBY
2384
DELISTED
Bed Bath & Beyond Inc
BBBY
| $114K | ﹤0.01% |
45,456
-262,570
| -85% | -$1.03M |
|
2385
Nurix Therapeutics
NRIX
$2.76B
| $113K | ﹤0.01% |
+10,332
| New | +$125K |
|
|
DSKE
2386
DELISTED
Daseke, Inc. Common Stock
DSKE
| $112K | ﹤0.01% |
+19,601
| New | +$116K |
|
2387
Zegna
ZGN
$3.76B
| $111K | ﹤0.01% |
+10,626
| New | +$115K |
|
|
KC
2388
Kingsoft Cloud Holdings
KC
$3.52B
| $109K | ﹤0.01% |
+28,496
| New | +$81.9K |
|
2389
Neuropace
NPCE
$496M
| $108K | ﹤0.01% |
72,508
-323,238
| -82% | -$718K |
|
2390
IonQ
IONQ
$18.3B
| $107K | ﹤0.01% |
+30,880
| New | +$149K |
|
2391
Bausch Health
BHC
$2.32B
| $106K | ﹤0.01% |
16,936
| – | – |
|
|
ORGN
2392
DELISTED
Origin Materials
ORGN
| $106K | ﹤0.01% |
765
+262
| +52% | +$41.7K |
|
|
PVBC
2393
DELISTED
Provident Bancorp
PVBC
| $105K | ﹤0.01% |
+14,409
| New | +$146K |
|
2394
Sutro Biopharma
STRO
$353M
| $104K | ﹤0.01% |
+1,282
| New | +$89.1K |
|
|
ALLK
2395
DELISTED
Allakos
ALLK
| $102K | ﹤0.01% |
+12,150
| New | +$84.4K |
|
2396
Sotera Health
SHC
$5.39B
| $102K | ﹤0.01% |
+12,243
| New | +$91.4K |
|
2397
Opko Health
OPK
$1.04B
| $99.9K | ﹤0.01% |
79,917
+27,616
| +53% | +$43.5K |
|
2398
MacroGenics
MGNX
$256M
| $99.3K | ﹤0.01% |
+14,792
| New | +$81.1K |
|
2399
Magnachip Semiconductor
MX
$139M
| $94.7K | ﹤0.01% |
+10,082
| New | +$97.4K |
|
2400
Medallion Financial
MFIN
$257M
| $94.5K | ﹤0.01% |
+13,238
| New | +$92.8K |
|
Similar funds
American Century Companies's Q4 2022 Portfolio in Review
As of Q4 2022, American Century Companies held 2,650 positions worth $122B, up 7.7% from $114B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
American Century Companies's Q4 2022 filing shows 220 new, 1,560 increased, 662 reduced and 73 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 903,403 shares worth $45.5M. The largest sale was Alphabet (Google) Class A, an estimated $265M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 903,403 shares worth $45.5M.
- American Century Companies added most to MarketAxess Holdings in Q4 2022, an estimated $239M increase.
- American Century Companies's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $265M.
- American Century Companies fully exited Abiomed Inc in Q4 2022, selling an estimated $96.8M.
- American Century Companies's ten largest holdings make up 19% of its $122B portfolio in Q4 2022.
- American Century Companies opened 220 new positions and closed 73 in Q4 2022.
- American Century Companies's portfolio value rose 7.7% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q4 2022, filed 13 Feb 2023.